| Modulators of 5' nucleotidase, ecto and the use thereof |
2023-3-02 |
2023-4-06 |
|
| Anti-tigit antibodies |
2022-12-01 |
2023-2-16 |
|
| Inhibitor of adenosine 5'-nucleotidase |
2022-9-30 |
2022-11-18 |
|
| TETRALINE AND TETRAHYDROQUINOLINE COMPOUNDS AS HIF-2ALPH INHIBITORS |
2022-9-16 |
2022-11-15 |
|
| Azolopyrimidine for the treatment of cancer-related disorders |
2022-5-24 |
2022-6-09 |
|
| Axl compounds |
2022-5-20 |
2022-11-24 |
|
| Axl inhibitor compounds |
2022-5-20 |
2022-11-24 |
|
| Processes for preparing aminopyrimidine compounds |
2021-12-01 |
2022-2-01 |
|
| Crystalline forms of a cd73 inhibitor and uses thereof |
2021-6-17 |
2022-4-16 |
|
| Crystalline forms of a CD73 inhibitor and uses thereof |
2021-6-16 |
2023-4-07 |
|
| TETRALINE AND TETRAHYDROQUINOLINE COMPOUNDS AS HIF-2a INHIBITORS |
2021-3-18 |
2022-6-22 |
|
| Solid forms of an azolopyrimidine compound |
2021-1-13 |
2021-11-08 |
|
| HIF-2a INHIBITORS |
2020-12-04 |
2022-3-09 |
|
| Arginase inhibitors |
2020-9-29 |
2021-1-18 |
|
| 2,3,5-PYRAZOLE[1,5-A]TRI-SUBSTITUTED PYRIMIDINE COMPOUNDS |
2020-6-04 |
2021-11-24 |
|
| Treatment of cancer utilizing an identified adenosine fingerprint |
2020-3-27 |
2021-10-28 |
|
| Treatment of oncogene-driven cancers |
2020-3-11 |
2022-11-16 |
|
| Solid forms of a cd73 inhibitor and the use thereof |
2019-12-13 |
2020-11-01 |
|
| Inhibitors of arg1 and/or arg2 |
2019-11-15 |
2020-9-16 |
|
| Cd73 inhibitors |
2019-8-26 |
2021-7-07 |
|
| Pyridone a2r antagonists |
2019-7-26 |
2022-4-27 |
|
| Immunity-enhancing drugs administered parenterally |
2019-3-08 |
2020-11-20 |
|
| Dosing with an azolopyrimidine compound |
2019-2-15 |
2020-1-01 |
|
| Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders |
2018-5-16 |
2022-1-11 |
2022-1-11 |
| QUINAZOLINE-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS |
2018-5-04 |
2018-10-31 |
|
| QUINAZOLINE-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS |
2018-5-04 |
2019-8-07 |
|
| Quinazoline-pyridine derivatives for the treatment of diseases associated with … |
2018-5-03 |
2023-4-14 |
2023-4-14 |
| AZOLOPIRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS |
2018-1-19 |
2019-5-02 |
|
| Azolopyrimidine for the treatment of cancer-related disorders |
2018-1-19 |
2021-9-06 |
|
| Inhibitors of cd73-mediated immunosuppression |
2017-11-17 |
2020-2-27 |
|
| Inhibitors of adenosine 5' -nucleotidase |
2017-10-02 |
2023-4-04 |
2023-4-04 |
| Cd73抑制剂的结晶形式及其用途 |
2021-6-16 |
2023-4-07 |
|
| 治疗与癌症有关疾病的喹唑啉-吡啶衍生物 |
2018-5-03 |
2023-4-14 |
2023-4-14 |
| 腺苷5′-核苷酸酶的抑制剂 |
2017-10-02 |
2023-4-04 |
2023-4-04 |